Treatments and Specialities
Each treatment is designed with a protocol and dosage specific to the patient and the condition.
The medicinal product is manufactured on an individual basis in a cleanroom under pharmaceutical manufacturing standards, from the patient's own cultured cells.
Clinical follow-up is maintained over the long term with objective documentation of each case.
Tendon injuriesCMC administered intratendinously has demonstrated structural regeneration in the patellar, Achilles, hamstring, and supraspinatus tendons, validated by MRI and associated with sustained functional improvement.
Intervertebral disc injuriesIn lumbar disc degeneration, intradiscal administration of CMC has shown structural recovery on MRI and sustained pain reduction, with extended clinical follow-up.
Cartilage injuriesITRT has evaluated CMC in osteoarthritis of the knee, hip, shoulder, and other peripheral joints, whether degenerative or post-traumatic, with clinical evidence of cartilage regeneration and functional improvement.

































